Efficacy and Safety of SYN-010 in IBS-C

Condition:   Irritable Bowel Syndrome With Constipation Interventions:   Drug: SYN-010 21 mg;   Drug: SYN-010 42 mg;   Drug: Placebo Sponsors:   Cedars-Sinai Medical Center;   Synthetic Biologics Inc. Not yet recruiting

Source: ClinicalTrials.gov - December 4, 2018 Category: Research Source Type: clinical trials